Dorzolamide Hydrochloride

Dorzolamide Hydrochloride is a medication commonly used in the treatment of glaucoma, a condition characterized by increased intraocular pressure that can lead to vision loss. This compound is a carbonic anhydrase inhibitor, which works by reducing the production of aqueous humor in the eye, thereby lowering intraocular pressure. Dorzolamide Hydrochloride is typically administered in the form of eye drops, providing a localized effect with minimal systemic absorption. Its efficacy in managing both open-angle glaucoma and ocular hypertension makes it a valuable option in the therapeutic arsenal against these conditions. Additionally, it is often used in combination with other glaucoma medications to enhance treatment outcomes. The drug is well-tolerated, with a safety profile that includes mild side effects such as burning or stinging upon application.